Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avidan U Neumann

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Plos Pathogens|April 14, 2017
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Journal of Hepatology|June 22, 2010
Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomesHarel Dahari, Evaldo S Affonso de Araujo, Bart L Haagmans, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2010
Pharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patientsEvaldo Stanislau Affonso de Araujo, Harel Dahari, Scott J Cotler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIVAndrew H Talal, M Tarek Shata, Marianthi Markatou, et al.
Biomolecules|July 29, 2023
Combining 16S Sequencing and qPCR Quantification Reveals <i>Staphylococcus aureus</i> Driven Bacterial Overgrowth in the Skin of Severe Atopic Dermatitis PatientsAmedeo De Tomassi, Anna Reiter, Matthias Reiger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 13, 2025
Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cellsAlexander Dermietzel, Burcu Tosun, Mathilde Nguyen, et al.
Kidney International|July 30, 2015
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patientsBenjamin J D Weist, Patrizia Wehler, Linda El Ahmad, et al.
Journal of Hepatology|July 20, 2002
The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudineLeonieke M M Wolters, Bettina E Hansen, Hubert G M Niesters, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Plos Pathogens|April 14, 2017
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Journal of Hepatology|June 22, 2010
Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomesHarel Dahari, Evaldo S Affonso de Araujo, Bart L Haagmans, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2010
Pharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patientsEvaldo Stanislau Affonso de Araujo, Harel Dahari, Scott J Cotler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIVAndrew H Talal, M Tarek Shata, Marianthi Markatou, et al.
Biomolecules|July 29, 2023
Combining 16S Sequencing and qPCR Quantification Reveals <i>Staphylococcus aureus</i> Driven Bacterial Overgrowth in the Skin of Severe Atopic Dermatitis PatientsAmedeo De Tomassi, Anna Reiter, Matthias Reiger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 13, 2025
Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cellsAlexander Dermietzel, Burcu Tosun, Mathilde Nguyen, et al.
Kidney International|July 30, 2015
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patientsBenjamin J D Weist, Patrizia Wehler, Linda El Ahmad, et al.
Journal of Hepatology|July 20, 2002
The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudineLeonieke M M Wolters, Bettina E Hansen, Hubert G M Niesters, et al.
Pageof 9